ELICIO THERAPEUTICS INC (ELTX) Stock Income Statement
NASDAQ:ELTX • US28657F1030
Current stock price
10.44 USD
-0.38 (-3.51%)
Last:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 2.30M | 28.31M | 2.88M | |||
| Cost Of Goods | N/A | N/A | 0.00 | 430.00K | 1.19M | |||
| Gross Profit | N/A | N/A | 2.30M | 27.88M | 1.69M | |||
| Operating Expenses | 45.00M | 35.74M | 32.73M | 67.19M | 56.96M | |||
| Research and Development | N/A | 23.85M | 18.10M | 48.70M | 38.98M | |||
| Selling, General, and Administrative Expenses | 11.00M | 11.90M | 14.64M | 18.49M | 17.99M | |||
| Operating Income | -45.00M | -35.74M | -30.43M | -39.31M | -55.27M | |||
| Interest Income/Expense | N/A | -53.00K | 720.00K | -2.19M | -8.25M | |||
| Other Income/Expense | -7.39M | -2.00K | 100.00K | -13.98M | -16.53M | |||
| Non Recurring Items | 0.00 | 605.00K | -9.19M | 910.00K | N/A | |||
| Income Before Taxes | -52.00M | -35.20M | -38.81M | -54.57M | -80.11M | |||
| Income Tax | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Net Income | -52.00M | -35.20M | -38.81M | -54.57M | -80.11M | |||
| EBITDA | -44.68M | -35.36M | -30.25M | -39.22M | -55.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.33 | -6.96 | -12.92 | -19.35 | -54.12 | |||
| Non GAAP EPS | -4.20 | N/A | -12.90 | -20.90 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 100.00% | 98.48% | 58.68% | |||
| Profit Margin | N/A | N/A | -1687.39% | -192.76% | -2781.60% | |||
| Operating Profit Margin | N/A | N/A | -1323.04% | -138.86% | -1919.10% | |||
All data in USD